松原股份(300893.SZ):與某歐洲知名汽車製造商S客户簽署《供貨合同》
格隆匯7月26日丨松原股份(300893.SZ)公佈,近日與某歐洲知名汽車製造商S客户簽署《供貨合同》。公司獲得該客户S平台及相關項目定點,公司作為該客户合格供應商,將為以下平台車型提供被動安全系統相關產品,分別為:1、F平台某項目,供貨產品為前後排安全帶,生命週期8年,生命週期內產量總計約158萬台,銷售額摺合人民幣約7.29億元;2、S平台某項目,供貨產品為前後排安全帶,生命週期8年,生命週期內產量總計約595萬台,銷售額摺合人民幣約36.27億元;3、S平台某項目,供貨產品為氣囊,生命週期8年,生命週期內產量總計約595萬台,銷售額摺合人民幣約9億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.